Treatment of thrice-negative breast cancer in a patient with metabolic syndrome
Open Access
- 10 March 2021
- journal article
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 8 (1), 62-68
- https://doi.org/10.17709/2409-2231-2021-8-1-6
Abstract
Breast cancer (BC) remains one of the most common diseases of the female population. According to statistics, breast cancer is detected in every eighth woman. Approximately 20‑24% of breast cancer patients are diagnosed with triple negative breast cancer. Triple‑negative breast cancer is characterized by an aggressive clinical course, a higher relapse rate, and low overall survival. According to statistics, the median survival rate for women with metastatic triple‑negative breast cancer is less than one year. We demonstrate a successful case of treatment of a 60‑year‑old woman diagnosed with triple negative breast cancer on the right, edematous‑infiltrative form, St IIIC cT4bN3M0 on the background of metabolic syndrome. Antitumor treatment lasted 1 year and consisted of three stages: systemic chemotherapy, surgical treatment (radical mastectomy), and adjuvant radiation therapy. After the treatment, remission was achieved. The patient is alive and has a relapse‑free period of 3 years.Conclusion.Despite the severe concomitant pathology in the observed patient, we received a positive result of multi‑ stage therapy, where cytotoxic chemotherapy was the basic treatment for a woman with triple negative breast cancer.Keywords
This publication has 16 references indexed in Scilit:
- The Interactions of Obesity, Inflammation and Insulin Resistance in Breast CancerCancers, 2015
- Retrospective analysis of metastatic behaviour of breast cancer subtypesBreast Cancer Research and Treatment, 2015
- Subtyping of triple‐negative breast cancer: Implications for therapyCancer, 2014
- Progression from High Insulin Resistance to Type 2 Diabetes Does Not Entail Additional Visceral Adipose Tissue InflammationPLOS ONE, 2012
- Triple-Negative Breast CancerThe New England Journal of Medicine, 2010
- Physical Activity and Breast Cancer: Review of the Epidemiologic Evidence and Biologic MechanismsPublished by Springer Science and Business Media LLC ,2010
- Body Size and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer in Postmenopausal WomenCancer Epidemiology, Biomarkers & Prevention, 2008
- Triple-Negative Breast Cancer: Clinical Features and Patterns of RecurrenceClinical Cancer Research, 2007
- Association between diabetes mellitus and adverse characteristics of breast cancer at presentationEuropean Journal of Cancer, 2006
- Body Mass and Mortality After Breast Cancer DiagnosisCancer Epidemiology, Biomarkers & Prevention, 2005